Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
about
MIF signal transduction initiated by binding to CD74Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activityMIF: Implications in the Pathoetiology of Systemic Lupus ErythematosusAbrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasionA Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responsesStructural and Kinetic Analyses of Macrophage Migration Inhibitory Factor Active Site Interactions † ‡A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitorsRole of macrophage migration inhibitory factor in age-related lung diseaseInsight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptorMacrophage Migration Inhibitory Factor as an Emerging Drug Target to Regulate Antioxidant Response Element SystemA Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent InhibitorsThe macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF)Receptor agonists of macrophage migration inhibitory factor.The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory interventionBenzisothiazolones as modulators of macrophage migration inhibitory factor.Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.Similarities in features of autism and asthma and a possible link to acetaminophen useRole of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension.Paracetamol use and risk of ovarian cancer: a meta-analysisA new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel diseaseAugmenting the Activity of Monoterpenoid Phenols against Fungal Pathogens Using 2-Hydroxy-4-methoxybenzaldehyde that Target Cell Wall Integrity.Spirohexenolide A targets human macrophage migration inhibitory factor (hMIF)Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanatesHypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor.
P2860
Q24303802-2B5FF693-7365-421B-A30E-1D2DCCE66DC9Q24631636-66562555-AFE1-4151-977C-E8198528D15CQ26776111-B3E99975-F647-4DA0-A3ED-7822AAD1920DQ27481089-05F99685-4390-4E9D-81FB-1DEAE7AF03C7Q27650742-DF559E19-C81F-47AA-8326-D1783D28A5AAQ27653174-C03A6F99-5E3B-45F5-A40A-CD4280DF39FDQ27670700-71229323-134E-4BFA-AC48-0140F47F2126Q27728051-6647693C-F547-42E9-BF89-A22C16F2FE92Q28081711-39876B46-1036-4D1F-847B-210170317607Q28297046-DF3409E5-A40A-4D39-B89E-63AAC9B6B3C1Q28817936-AFF271C1-20DE-454C-B805-ECAAD6A40014Q28830113-4E6B88DD-6B64-4380-B4AA-A1C7D095F7ECQ30407722-28BA48C6-CBCA-4D8E-A542-23AFCC230FAFQ30415763-B5AB8E33-9D23-4F48-B05A-654AA606B3BEQ33500775-875D2108-3070-4A1E-B5BA-137409A59C44Q33591955-F5FF6545-5CFD-4612-B544-8DCE50C94760Q34018060-0E1AAEC5-688B-4E9E-B87C-DDDE2B72DE1AQ34124862-E73C87CC-1B0D-4893-8B56-BDF682241079Q34127116-2DA6D8BB-854A-4985-9C32-965823767330Q34340164-B4E60C0E-03AF-46AF-8ADB-59BEF4322B79Q34347558-0646FABE-5460-4D83-BF35-52D7AFA56700Q35071632-61CC4FF4-E244-44F2-9E43-C36FECEFC0C4Q35081105-6425CD17-AE15-4B19-B44A-F247679ECCE1Q35093950-21753A2E-A69D-487E-AE2D-264B965389ABQ35114713-F23F1791-3029-4A25-A869-993A9619DDDDQ35285019-1C73DE17-8F3B-416F-A6C0-68325EE07225Q35682240-7BB77F51-5748-4323-B78E-76A664248496Q35725571-B0E4B603-2F4B-44FF-8D3E-AD40072552BCQ35827624-2F65ED48-723B-408D-9FC1-66D5F2189969Q36014080-4EA96571-6DE5-47DF-B25D-B71C8AB013F6Q36324591-48444E69-3E4D-483C-9AB0-148C27650533Q36996170-DB21B3D1-5F27-4FF6-8823-9831B3E90CDDQ37187080-2FC6EE3A-E526-4117-83AD-BBA35D430C40Q37187775-416EC2CE-21CE-43C8-9DBF-EA159EE154ABQ37431990-4F9E982A-8BE4-42BE-9ACB-2556E5425179Q38351825-7BDB5EDB-4C37-41A0-99D4-FBC83D5C77C9Q38700157-472315DB-203A-4023-ABE2-59E90AB03DBFQ38735389-0BE71678-B1C9-47A2-AF44-AD1AD466B3BEQ39340752-A3A09F85-95F1-4D99-8C60-7F596E66F72AQ39849398-1DDF40BC-907C-4174-8DFA-7E69A3795F57
P2860
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@ast
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@en
type
label
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@ast
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@en
prefLabel
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@ast
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@en
P2093
P2860
P356
P1476
Inhibition of macrophage migra ...... by acetaminophen metabolites.
@en
P2093
Carlos G Gartner
Christine N Metz
Fabio Benigni
George J Todaro
Jianlin Han
Peter D Senter
Robert A Mitchell
Sidney D Nelson
Yousef Al-Abed
P2860
P304
P356
10.1073/PNAS.011569399
P407
P577
2002-01-02T00:00:00Z